Our B12 injection program combines licensed medical oversight with personalized wellness support to help you feel your best
BPC-157, CJC-1295, Semaglutide, NAD+, and custom peptide stacks available
Therapy with a GLP-1 RA or sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) that has proven CV benefit is recommended for initial therapy, with or without metformin based on glycemic needs, in patients with indicators of high-risk or established CV disease
The factors have proadhesive, proinflammatory, and prothromobic roles, all of which become pertinent after vascular injury (Schweighofer et al., 2007
Its important to know the differences to treat patients well
Lets look at which of these molecules help transform the way you rest and recharge and how they do it